Longevity Vision Fund and SALT Fund are the most recent investors. Disability Disability Veteran Status Want more demographic options Non-disabled (5) 3.4 People with Disabilities 5. Tessera Therapeutics is funded by 13 investors. This rating reflects the overall rating of Tessera Therapeutics and is not affected by filters. Their latest funding was raised on from a Series C round. This brings Tessera's total funding to $530M to date. a cofounder of Intellia Therapeutics and a Scientific Advisory Board member at Tessera Therapeutics. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the. Tessera Therapeutics has raised a total of 531.8M in funding over 3 rounds. The company raised over $300M in Series C round on Apr 19, 2022. Tessera is backed by Flagship Pioneering, Abu Dhabi Investment Authority (ADIA), SoftBank Vision Fund 2, Qatar Investment Authority (QIA), Alaska Permanent Fund Corporation, Altitude Life Science Ventures, ARTIS Ventures, Cormorant Asset Management, and others. Tessera has evaluated tens of thousands of natural and synthetic MGEs to create GENE WRITER candidates with the ability to write therapeutic messages into the human genome. The GENE WRITING platform allows the correction of single nucleotides, the deletion or insertion of short sequences of DNA, and the writing of entire genes into the genome, offering the potential for a new category of genetic medicines with broad applications both in vivo and ex vivo. Tessera's GENE WRITING consists of multiple technology platforms designed to offer scientists and clinicians the ability to write therapeutic messages into the human genome, thereby curing diseases at their source. The company is headquartered in Cambridge, Massachusetts. Tessera Therapeutics was founded by Flagship Pioneering in 2018. Tessera Therapeutics is an early-stage life sciences company pioneering Gene Writing, a new biotechnology designed to offer scientists and clinicians the ability to write small and large.
#TESSERA THERAPEUTICS CODE#
Tessera Therapeutics' mission is to cure disease by writing in the code of life. Tessera is a biotechnology company pioneering a new approach in genetic medicine known as GENE WRITING technology.
0 kommentar(er)
